ArticlemBio2026
PDCoV NSP5 cleaves the selective autophagy receptor CCDC50 to disrupt autophagic degradation of the viral envelope protein.
Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selective autophagy is a critical host defense mechanism that eliminates viral components through lysosomal degradation during coronavirus infection. Coronaviruses (CoVs), however, deploy countermeasures that disrupt this process, and several underlying mechanisms remain unresolved. Here, we identify the autophagy receptor CCDC50 as a substrate of the coronavirus-encoded NSP5 protease. During porcine deltacoronavirus (PDCoV) infection, NSP5 cleaves CCDC50 at glutamine 171 (Q171), a conserved site also processed by NSP5 from PEDV, TGEV, and SARS-CoV-2. Functionally, CCDC50 restricts PDCoV replication by recognizing the envelope (E) protein when it is modified with K63-linked polyubiquitin at lysine 72 (K72) and routing it for autophagic degradation, independently of canonical receptors such as SQSTM1/p62 and NBR1. NSP5-mediated cleavage disrupts CCDC50 interaction with LC3 and ubiquitin, reduces its capacity to target E for degradation, and thereby compromises its antiviral activity. Taken together, our study identifies CCDC50 as a previously uncharacterized antiviral autophagy receptor in coronavirus infection and reveals that PDCoV circumvents this defense through NSP5-mediated cleavage to promote productive infection.IMPORTANCEIn our study, we investigated the interplay between host autophagy pathways and coronavirus infection. We identified the selective autophagy receptor CCDC50 as a potent antiviral factor that suppresses porcine deltacoronavirus (PDCoV) replication. We demonstrated that CCDC50 specifically recognizes the viral envelope (E) protein and targets it for autophagic degradation, thereby restricting the virus. However, we also uncovered a sophisticated viral escape mechanism. We found that PDCoV's main protease, NSP5, cleaves CCDC50 directly at a specific residue, glutamine 171. This proteolytic event impairs the ability of CCDC50 to interact with ubiquitin and the core autophagy machinery, effectively neutralizing its antiviral function and promoting viral replication. Significantly, we determined this to be a highly conserved strategy among coronaviruses. Our findings show that the NSP5 proteases of other divergent coronaviruses, including PEDV, TGEV, and even SARS-CoV-2, all target the same conserved site in CCDC50. These results reveal a common mechanism that coronaviruses use to subvert selective host autophagy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.